Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours

Aditya Bagrodia, Anna Savelyeva, John T. Lafin, Ryan W. Speir, Gregory T. Chesnut, Anne Lindsay Frazier, Solomon L. Woldu, Vitaly Margulis, Matthew J. Murray, James F. Amatruda, Yair Lotan